Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs.
about
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.Levetiracetam in the treatment of epilepsyThe Impact of Anti-Epileptic Drugs on Growth and Bone MetabolismPathophysiological implications of neurovascular P450 in brain disordersClinically and pharmacologically relevant interactions of antidiabetic drugsThe treatment of depressive disorders in epilepsy: what all neurologists should knowOn the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringCannabinoids and Epilepsy.Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.Role of valproate across the ages. Treatment of epilepsy in the elderly.In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients.Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07Antiepileptic drug interactions - principles and clinical implications.Hepatic enzyme induction: it does really matterProperties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs.Incidence of Potential Drug-Drug Interaction and Related Factors in Hospitalized Neurological Patients in two Iranian Teaching Hospitals.Large-scale identification and analysis of suppressive drug interactions.Chronic phenytoin therapy-induced vecuronium resistance.Citrus aurantium increases seizure latency to PTZ induced seizures in zebrafish thru NMDA and mGluR's I and II.Clinically significant psychotropic drug-drug interactions in the primary care setting.Treatment strategies in the postictal state.Clinically relevant drug interactions with antiepileptic drugsAn overview of the evidence and mechanisms of herb-drug interactions.The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liverPharmacokinetics and drug interactions with zonisamide.Safe Treatment of Seizures in the Setting of HIV/AIDS.Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.Value of therapeutic drug monitoring in epilepsy.Brain tumors and epilepsy.Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)The preoperative neurological evaluation.Therapeutic drug monitoring of phenytoin in critically ill patients.Pregabalin in the management of partial epilepsyTreatment of tuberculosis in children.Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications.Drug interactions involving the new second- and third-generation antiepileptic drugs.State of the art in therapeutic drug monitoring.Seizures in low- and high-grade gliomas: current management and future outlook.
P2860
Q24630240-30B2C261-A7C4-4B5B-8B24-9F9ED184FA0FQ24656333-313E449A-8403-4945-A38A-A26C341BAF6FQ26739054-45D7D11D-DA1A-4DE9-B67D-CF758C7D803EQ26745632-D118B42F-2DEE-4DBB-B250-BE7A34C89F54Q26752468-AAD178A5-DA05-451D-A251-492C90CF39D1Q26851858-D8E93FCB-3CAE-4C96-94FE-ECFF89AA8250Q27024074-C0D6F65D-21C6-44B2-909A-9BF846A46FA6Q27336451-47A20D8C-DD10-4BE4-9950-1C7AC31EA44EQ30724630-34572FB8-9BBA-4B16-9D0A-2E77F204E770Q33153941-667B5066-FB86-41E6-B390-73F74EF35216Q33768138-8ACBFB1F-B423-49A5-9DB9-E766DF4F7664Q33868103-90CCA92F-DD68-454F-A6DB-BE2006782316Q34180457-D24F4BC8-7CBC-4FA3-90BE-2E630EFF2B21Q34402188-5C3D22FD-F269-4EB9-BFC6-8E8FB35E98BEQ34465482-413B0B69-71F8-49C4-9B8E-A7608F7AF938Q34469479-1C1A158B-C6D4-4E4B-9595-1385B2995594Q34559174-E6F7D1AE-E698-4836-A190-E46CD8C6284AQ34567387-B1A38DEA-2859-438B-85D1-B9AE4CB6AABFQ34799147-41C02F45-7210-4050-AA68-CB64338A0956Q34844234-1816E8D2-57E2-4CA6-82DD-67945B3C354AQ35082329-E0CE4944-23D8-42DB-BACB-47D6FFFF0A18Q35104220-0AC805A4-B157-4FD0-A5E1-B4A7E1E3ACCAQ35219937-A15AE49D-D03B-444C-8FB3-B328F5B93EDAQ35827491-0AA7D849-6D66-44F8-B5F7-DC80C94BC059Q35919968-0D57945F-4806-4061-80D2-341588DD716BQ36053511-82E9431B-9580-4F68-921A-F879ECEF9EA6Q36744156-AD3CF886-B4DE-4B6D-86BB-E3334FF71EB4Q37096562-0C3A0D88-ECC1-4352-AC97-C2343434E555Q37161513-6C5012D5-3ECC-4C6F-B99A-3BCE6955C5D1Q37174056-DDBC3F7B-2705-4A3A-B5A4-828AC3F8B18BQ37174060-9E309777-7B1A-4175-8473-D24A1345718DQ37242260-2F44B6E7-8A45-4515-B876-E44916020B74Q37262132-E89FCFB1-C5C9-48D9-A343-3FC302AAD889Q37310486-0B6B9E02-6217-41B7-A709-2F4E3B05C7ADQ37318734-DAF467EE-3BBB-4E4C-80DD-0FB463FBBDA1Q37340569-A0266F9B-9E1E-4B29-8DF0-E345D751FD9AQ37613566-F6B81A61-0AD5-46CE-9591-1453DCD9FF33Q37658910-F66C38A6-319B-47D8-B17A-CBD148E2CDF6Q37699413-B98CA39E-7CB1-46FA-B125-9C00CF937C61Q37752365-D3851CE4-B6B4-4B81-98D3-DCFB42566E57
P2860
Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinically important drug inte ...... ileptic drugs and other drugs.
@ast
Clinically important drug inte ...... ileptic drugs and other drugs.
@en
type
label
Clinically important drug inte ...... ileptic drugs and other drugs.
@ast
Clinically important drug inte ...... ileptic drugs and other drugs.
@en
prefLabel
Clinically important drug inte ...... ileptic drugs and other drugs.
@ast
Clinically important drug inte ...... ileptic drugs and other drugs.
@en
P1433
P1476
Clinically important drug inte ...... ileptic drugs and other drugs.
@en
P2093
Philip N Patsalos
P304
P356
10.1016/S1474-4422(03)00483-6
P577
2003-08-01T00:00:00Z